Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma
NCT05507775
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
8
Enrollment
OTHER
Sponsor class
Conditions
Non-Medullary Thyroid Carcinoma
Interventions
DRUG:
Digoxin tablet
Sponsor
Radboud University Medical Center